- Company
has retained Boustead Securities for underwriting of the planned IPO for
wholly owned foreign enterprise CBD Biotech
- CIIX
is taking necessary steps to support the growth strategy currently in
place for CBD Biotech
- With
the finalized spinoff of CBD Biotech, CIIX will look to refocus on its
original mission
ChineseInvestors.com, Inc. (OTCQB: CIIX), a leading
financial news media and content platform serving the global Chinese-speaking
community, recently announced (http://ibn.fm/JRGbs) that it has retained Boustead
Securities, LLC for the underwriting of the planned initial public offering
(IPO) of its wholly owned foreign enterprise, CBD Biotech Co. Ltd.
According to Warren Wang, founder, CEO and chairman of CIIX,
this is one of many steps in place to execute the planned spinoff of CBD
Biotech. Wang believes that listing on a national exchange will add value to
the company by providing market visibility and access to capital, while further
supporting the growth strategy that’s currently in place. In the press release,
Boustead Securities emphasized the potential that CBD Biotech can gain by being
a first mover in the Chinese CBD market.
The company has already made positive steps toward
increasing CBD Biotech’s visibility and accessibility on a global scale. A few
of the steps that have been taken over the last year include:
- Launched
the world’s first CBD health products store published in the Chinese
language, www.ChineseCBDOil.com
- Launched
the world’s first cannabis-focused social media mobile app created for
Chinese-speaking customers, Da Ma Dian Ping
- Appointed
a chief financial officer, Alex Hamilton, with the goal of providing
CBD-related products to China’s mainland population (http://ibn.fm/bd0c8)
With the finalized spinoff of CBD Biotech, CIIX will be able
to re-focus on its original mission of providing financial information and
services to the larger Chinese community in the U.S. and elsewhere. Over the
years, the company has invested heavily in a variety of products and services
for education of Chinese-speaking investors worldwide. These resources include
real-time market analysis, commentaries and educational products that allow the
CIIX audience to make informed decisions to help meet their individual
financial goals.
The company has a diversified line of products and services
to expand revenue streams. This includes the CBD products, the financial
information products and services and a consultative service for private
companies looking to go public.
For more information, visit the company’s website at www.ChineseInvestors.com
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
